Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Parallel Group Open-Label Multicenter Study to Assess the Potential for Adrenal Supp and Syst Drug Abs Following Multi Dosing With DFD-01 (Betamethasone Dipropionate) Spray 0.05% in Adol Subjects With Mod to Sev Plaque Psoriasis

NCT02070965 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.

NCT NCT02070965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Parallel Group Open-Label Multicenter Study to Assess the Potential for Adrenal Supp and Syst Drug Abs Following Multi Dosing With DFD-01 (Betamethasone Dipropionate) Spray 0.05% in Adol Subjects With Mod to Sev Plaque Psoriasis
Lead sponsor
Primus Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
October 31, 2014
Enrollment
75 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis